To evaluate whether cotrimoxazole prophylaxis prevents common skin conditions in HIV-infected children.
Open-label randomized controlled trial of continuing versus stopping daily cotrimoxazole (post-hoc analysis).
Three sites in Uganda, one in Zimbabwe.
758 children aged >3 years receiving antiretroviral therapy (ART) for >96 weeks in the ARROW trial were randomized to stop (n=382) or cont...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Lippincott, Williams & Wilkins Publisher's website
- AIDS Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- Wolters Kluwer Health, Inc
- Copyright date:
- Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Published under open access
Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
If you are the owner of this record, you can report an update to it here: Report update to this record